The Bladder Cancer Content Hub Channel

Combination Therapy May Provide Synergies for Some Patients with Bladder Cancer

0:42 | Bladder Cancer Content Hub, Internal Medicine, Men's Health, Oncology / Hematology, Urology, Women’s Health

Multiple clinical trials are currently underway examining the possible synergistic effects of combining chemotherapy with immunotherapies for patients with bladder cancer and other metastases.

More in Bladder Cancer Content Hub

► 1:14

New DNA Test Detects Mutations in Urine of Bladder Cancer Patients Over a Decade Before Diagnosis

Bladder Cancer Content Hub

Bladder cancer prognosis is more favorable when caught early. Danish researchers recently presented a study where they used urine from cancer patients to detect mutations common in bladder cancer. The...

► 1:15

Bladder Sparing Trimodal Therapy Evaluated for Clinical Efficacy in Retrospective Study

Bladder Cancer Content Hub

Bladder sparing trimodal therapy (TMT) and cystectomy were studied in a retrospective propensity score analysis. The study included 112 patients with a mean follow-up time of 4.5 years. Both therapies...

► 1:10

Genomic Test May Predict Which Patients Would Benefit Most from Checkpoint Inhibition

Bladder Cancer Content Hub

New genomic test could determine the patients who would benefit most from immunotherapy. Foundation Medicine, a molecular diagnostics company out of Cambridge, Massachusetts has created a test which determines a...

► :50

Updated Guidelines for Treatment of Non-Metastatic MBIC to be Presented at AUA Meeting

Bladder Cancer Content Hub

The American Urological Association, together with American Society of Clinical Oncology, the American Society for Radiation Oncology and the Society of Urologic Oncology, has released new guidelines for the treatment...